Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Laboratory For Synthetic Chemistry And Chemical Biology Limited is currently prosecuting a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The data shows 2 pending office actions, which are distributed between 2 distinct examiners. This arrangement indicates that each examiner is currently reviewing one of the company's active matters, allowing for simultaneous progress on different applications within the same technical field.
The prosecution activity is further organized across 2 distinct art units. This means that each of the 2 pending office actions is being handled within a separate administrative division of the patent office. LEE, HOI YAN NMN is identified as the busiest examiner for the company, currently managing 1 busiest examiner pending office action. This workload is shared equally with the other distinct examiner involved in the company's 2 total pending office actions.
The presence of 2 distinct examiners and 2 distinct art units for only 2 pending office actions suggests a diversified administrative approach. While the portfolio is focused on Biotechnology & Pharmaceuticals, the company must navigate the specific requirements and examination styles of two different art units. This distribution ensures that the company's patenting progress is not dependent on a single examiner or a single administrative unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, HOI YAN NMN | 1 | 37.5% | +76.2% |
| PIRO, NICHOLAS ANTHONY | 1 | 47.5% | +41.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18315937 | SYNTHESIS AND USES OF GINSENOSIDE COMPOUND K DERIVATIVES | LEE, HOI YAN NMN | 107d overdue |
| 17868214 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | PIRO, NICHOLAS ANTHONY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18315937 | SYNTHESIS AND USES OF GINSENOSIDE COMPOUND K DERIVATIVES | LEE, HOI YAN NMN | 107d overdue |
| 17868214 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | PIRO, NICHOLAS ANTHONY | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| 1738 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18315937 | SYNTHESIS AND USES OF GINSENOSIDE COMPOUND K DERIVATIVES | LEE, HOI YAN NMN | 1693 | §101§103§112 | Non-Final OA | 107d overdue | Pending | May 11, 2023 |
| 17868214 | BINUCLEAR GOLD(I) COMPOUNDS FOR PHOTOCATALYSIS APPLICATIONS | PIRO, NICHOLAS ANTHONY | 1738 | §103§112 | Non-Final OA | — | Pending | Jul 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLaboratory For Synthetic Chemistry And Chemical Biology Limited has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Hoi Yan Nmn Lee has the most, with 1 of Laboratory For Synthetic Chemistry And Chemical Biology Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
